Global Biologics Contract Development and Manufacturing Organization (CDMO) Market 2024-2028

The biologics contract development and manufacturing organization (CDMO) market is forecasted to grow by USD 10.63 bn during 2023-2028, accelerating at a CAGR of 10.46% during the forecast period. The report on the biologics contract development and manufacturing organization (CDMO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, strong research and development pipeline of biologics therapeutics, and growing need to focus on core competencies.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	9.65%
CAGR	10.46%
Incremental Value	$10.63bn

Technavio's biologics contract development and manufacturing organization (CDMO) market is segmented as below:

By Type

Mammalian
Microbial

By Product Type

Biologics
Biosimilars

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of big data as one of the prime reasons driving the biologics contract development and manufacturing organization (CDMO) market growth during the next few years. Also, strategic alliances and partnerships of CDMO vendors with pharma companies and increasing approvals for new molecules and biosimilars will lead to sizable demand in the market.

The report on the biologics contract development and manufacturing organization (CDMO) market covers the following areas:

Biologics contract development and manufacturing organization (CDMO) market sizing
Biologics contract development and manufacturing organization (CDMO) market forecast
Biologics contract development and manufacturing organization (CDMO) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologics contract development and manufacturing organization (CDMO) market vendors that include 3P BIOPHARMACEUTICALS S.L.U, AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals Co. Ltd, Catalent Inc., Evonik Industries AG, FUJIFILM Corp., Grifols SA, J RETTENMAIER and SOHNE GmbH and Co KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Electronics Co. Ltd., Shenzhen Hepalink Pharmaceutical Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Inc.. Also, the biologics contract development and manufacturing organization (CDMO) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72001

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global biologics contract development and manufacturing organization (CDMO) market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global biologics contract development and manufacturing organization (cdmo) market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 Product Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Mammalian - Market size and forecast 2023-2028
Exhibit 34: Chart on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Mammalian - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Mammalian - Year-over-year growth 2023-2028 (%)
6.4 Microbial - Market size and forecast 2023-2028
Exhibit 38: Chart on Microbial - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Microbial - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Microbial - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Microbial - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Product Type

7.1 Market segments
Exhibit 44: Chart on Product Type - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product Type - Market share 2023-2028 (%)
7.2 Comparison by Product Type
Exhibit 46: Chart on Comparison by Product Type
Exhibit 47: Data Table on Comparison by Product Type
7.3 Biologics - Market size and forecast 2023-2028
Exhibit 48: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
7.4 Biosimilars - Market size and forecast 2023-2028
Exhibit 52: Chart on Biosimilars - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Biosimilars - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Biosimilars - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Biosimilars - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product Type
Exhibit 56: Market opportunity by Product Type ($ billion)
Exhibit 57: Data Table on Market opportunity by Product Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 107: AbbVie Inc. - Overview
Exhibit 108: AbbVie Inc. - Product / Service
Exhibit 109: AbbVie Inc. - Key news
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Binex Co. Ltd.
Exhibit 111: Binex Co. Ltd. - Overview
Exhibit 112: Binex Co. Ltd. - Product / Service
Exhibit 113: Binex Co. Ltd. - Key offerings
12.5 Boehringer Ingelheim International GmbH
Exhibit 114: Boehringer Ingelheim International GmbH - Overview
Exhibit 115: Boehringer Ingelheim International GmbH - Business segments
Exhibit 116: Boehringer Ingelheim International GmbH - Key news
Exhibit 117: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 118: Boehringer Ingelheim International GmbH - Segment focus
12.6 Bora Pharmaceuticals Co. Ltd
Exhibit 119: Bora Pharmaceuticals Co. Ltd - Overview
Exhibit 120: Bora Pharmaceuticals Co. Ltd - Product / Service
Exhibit 121: Bora Pharmaceuticals Co. Ltd - Key offerings
12.7 Catalent Inc.
Exhibit 122: Catalent Inc. - Overview
Exhibit 123: Catalent Inc. - Business segments
Exhibit 124: Catalent Inc. - Key news
Exhibit 125: Catalent Inc. - Key offerings
Exhibit 126: Catalent Inc. - Segment focus
12.8 Evonik Industries AG
Exhibit 127: Evonik Industries AG - Overview
Exhibit 128: Evonik Industries AG - Business segments
Exhibit 129: Evonik Industries AG - Key news
Exhibit 130: Evonik Industries AG - Key offerings
Exhibit 131: Evonik Industries AG - Segment focus
12.9 FUJIFILM Corp.
Exhibit 132: FUJIFILM Corp. - Overview
Exhibit 133: FUJIFILM Corp. - Business segments
Exhibit 134: FUJIFILM Corp. - Key offerings
Exhibit 135: FUJIFILM Corp. - Segment focus
12.10 Grifols SA
Exhibit 136: Grifols SA - Overview
Exhibit 137: Grifols SA - Business segments
Exhibit 138: Grifols SA - Key offerings
Exhibit 139: Grifols SA - Segment focus
12.11 J RETTENMAIER and SOHNE GmbH and Co KG
Exhibit 140: J RETTENMAIER and SOHNE GmbH and Co KG - Overview
Exhibit 141: J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
Exhibit 142: J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
12.12 Lonza Group Ltd.
Exhibit 143: Lonza Group Ltd. - Overview
Exhibit 144: Lonza Group Ltd. - Business segments
Exhibit 145: Lonza Group Ltd. - Key news
Exhibit 146: Lonza Group Ltd. - Key offerings
Exhibit 147: Lonza Group Ltd. - Segment focus
12.13 Novartis AG
Exhibit 148: Novartis AG - Overview
Exhibit 149: Novartis AG - Business segments
Exhibit 150: Novartis AG - Key offerings
Exhibit 151: Novartis AG - Segment focus
12.14 Rentschler Biopharma SE
Exhibit 152: Rentschler Biopharma SE - Overview
Exhibit 153: Rentschler Biopharma SE - Product / Service
Exhibit 154: Rentschler Biopharma SE - Key offerings
12.15 Samsung Electronics Co. Ltd.
Exhibit 155: Samsung Electronics Co. Ltd. - Overview
Exhibit 156: Samsung Electronics Co. Ltd. - Business segments
Exhibit 157: Samsung Electronics Co. Ltd. - Key news
Exhibit 158: Samsung Electronics Co. Ltd. - Key offerings
Exhibit 159: Samsung Electronics Co. Ltd. - Segment focus
12.16 Toyobo Co. Ltd.
Exhibit 160: Toyobo Co. Ltd. - Overview
Exhibit 161: Toyobo Co. Ltd. - Business segments
Exhibit 162: Toyobo Co. Ltd. - Key offerings
Exhibit 163: Toyobo Co. Ltd. - Segment focus
12.17 WuXi Biologics Cayman Inc.
Exhibit 164: WuXi Biologics Cayman Inc. - Overview
Exhibit 165: WuXi Biologics Cayman Inc. - Product / Service
Exhibit 166: WuXi Biologics Cayman Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations